| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Surrozen, Inc./de (SRZN) has 13 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. SRZN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.02M | $29.44M | - | |
| 10% | 900.3K | $26.07M | - | |
| CFO | 50.0K | $1.45M | - | |
| VP | 16.1K | $466.0K | - | |
| COO | 13.0K | $376.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2020 | Livingston Kevin Harold | Chief Financial Officer | Buy | 24,000 | $0.00 | - | +5.9% | |
| Dec 1, 2020 | Soffer Benny | Director | Buy | 24,000 | $0.00 | - | +5.9% | |
| Dec 1, 2020 | Consonance Life Sciences | 10% Owner | Buy | 24,000 | $0.00 | - | +5.9% | |
| Dec 1, 2020 | Blutt Mitchell J Md | Director | Buy | 24,000 | $0.00 | - | +5.9% | |
| Nov 23, 2020 | Soffer Benny | Director | Buy | 410,000 | $0.00 | - | New | |
| Nov 23, 2020 | Blutt Mitchell J Md | Director, 10% Owner | Buy | 1,000,000 | $0.00 | - | New | |
| Nov 23, 2020 | Livingston Kevin Harold | Chief Financial Officer | Buy | 410,000 | $0.00 | - | New | |
| Nov 23, 2020 | Consonance Life Sciences | 10% Owner | Buy | 410,000 | $0.00 | - | New | |
| Nov 23, 2020 | Blutt Mitchell J Md | Director | Buy | 410,000 | $0.00 | - | New |